27 reports

Tdds (transdermal Drug Delivery Systems) Showing Promise in Topical Analgesics/ anaesthetic TDDS (transdermal drug delivery systems) is showing significant potential in topical analgesics/ anaesthetic.

  • Gastrointestinal Drug
  • Ophthalmic Solution
  • Pharmaceutical
  • China
  • Demand

It is developing ## National Grade new drugs, including ## National Grade Category No. ## new drugs and ## National Grade Category No. ## new drugs.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.

THE TECHNOLOGY ENABLES THE ORAL DELIVERY OF BIOLOGICS AND LIVE BIOTHERAPEUTIC DRUGS, AS WELL AS SYSTEMIC DELIVERY OF SENSITIVE DRUGS.

  • Gastrointestinal Drug
  • North America
  • United States
  • Market Size
  • MicroBiome Therapeutics LLC

They also allow development of specific targeted therapies with better drug delivery.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology

Safe if provided warnings are followed ##.

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited
  • CHEMOTHERAPY INDUCED NAUSEA AND VOMITING - PIPELINE BY SUDA LTD, H1 2018
  • CHEMOTHERAPY INDUCED NAUSEA AND VOMITING - PIPELINE BY SOLUBEST LTD, H1 2019

It is developed based on POZ drug delivery platform technology.

  • Gastrointestinal Drug
  • China
  • United States
  • Product Initiative
  • Helsinn Group
  • REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) - PIPELINE BY EISAI CO LTD, H2 2019
  • REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) - PIPELINE BY SAM-A PHARM CO LTD, H2 2019

The new drug is a Class ## innovative drug researched and developed by the Group.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Ironwood Pharmaceuticals, Inc.
  • SOLUBEST LTD
  • CHEMOTHERAPY INDUCED NAUSEA AND VOMITING - PIPELINE BY SUDA PHARMACEUTICALS LTD, H2 2018

In April 2009, IntelGenx Corp announced positive results for the Phase ## clinical trial of relivar, the first buccal dronabinol drug delivery product, which was developed using IntelGenx' proprietary AdVersa buccal delivery technology.

  • Chemotherapy
  • Gastrointestinal Drug
  • United States
  • Product Initiative
  • Helsinn Group

It has developed and applied several drug delivery technologies to patentable generics products such as orally disintegrating tablet platform, ophthalmic modified release systems, matrix systems, reservoir systems, modified-release delivery systems, osmotic pump systems, m

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative

The drug candidate is developed based on CDT (Controlled Delivery Technology) technology.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Company Operations
  • RedHill Biopharma Ltd.

The drug candidate is developed based on CDT (Controlled Delivery Technology) technology.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Company Operations
  • RedHill Biopharma Ltd.

Grunenthal also focuses on discovering new methods to treat pain, developing new medical devices, and new platform technologies for drug delivery.

  • Gastrointestinal Drug
  • Healthcare
  • Pharmaceutical
  • United States
  • Purdue Pharma L.P.
  • Jul 20, 2017: Ironwood Pharmaceuticals Reports Positive Top-line Results from IW-3718 Phase IIb Trial in Uncontrolled Gastroesophageal Reflux Disease
  • Clinical Trials

IW-## is a novel, gastric retentive formulation of a bile acid sequestrant, developed by Ironwood using the proprietary Acuform® drug delivery formulation technology licensed from Depomed, Inc.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Company Financials
  • Ironwood Pharmaceuticals, Inc.
  • COLESEVELAM - DRUG PROFILE

The company develops active pharmaceutical ingredients, formulations and drug delivery technologies for the treatment of cancer and inflammatory diseases.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) - PIPELINE BY TAKEDA PHARMACEUTICAL CO LTD, H1 2018
  • REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) - PIPELINE BY SUN PHARMA ADVANCED RESEARCH COMPANY LTD, H1 2018

It also concentrates its research in generics, novel drug delivery system; and new chemical entities.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Product Initiative
  • RaQualia Pharma Inc.
  • LATEST CLINICAL TRIALS NEWS ON REGURGITATION

About IW-## IW-## is a novel, gastric retentive formulation of colesevelam, a bile acid sequestrant, developed by Ironwood using the proprietary Acuform® drug delivery formulation technology licensed from Depomed, Inc.

  • Cardiovascular Disease
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • AstraZeneca PLC

THE DRUG CANDIDATE IS DEVELOPED BY USING CDT (CONTROLLED DELIVERY TECHNOLOGY) TECHNOLOGY.

  • Biopharmaceutical
  • Gastrointestinal Drug
  • Therapy
  • United States
  • RedHill Biopharma Ltd.
  • REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) - PIPELINE BY WOCKHARDT LTD, H2 2017
  • REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) - PIPELINE BY TAKEDA PHARMACEUTICAL COMPANY LTD, H2 2017

It also concentrates its research in generics, novel drug delivery system; and new chemical entities.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative

CCI encourages and invests in an innovative environment, leading to a string of inventions encompassing medical device, health IT, drugs and diagnostics, and delivery solutions.

  • Gastrointestinal Drug
  • Medical Device
  • United States
  • Company
  • EndoGastric Solutions, Inc.

Drug/ Molecule refers to Primary Intervention only. ##.

  • Clinical Trial
  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • World

Drug/ Molecule refers to Primary Intervention only. ##.

  • Chronic Pain
  • Clinical Trial
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Post Operative Nausea And Vomiting - Pipeline by Suda Ltd, H2 2016
  • Post Operative Nausea And Vomiting - Companies Involved in Therapeutics Development

The drug is based on oromist oral spray technology for systemic delivery.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • GW Pharmaceuticals plc
  • LATEST CLINICAL TRIALS NEWS ON REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE)

About IW-## IW-## is a novel, gastric retentive formulation of colesevelam, a bile acid sequestrant, developed by Ironwood using the proprietary Acuform® drug delivery formulation technology licensed from Depomed, Inc.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • CONSTIPATION - PIPELINE BY ZENSUN (SHANGHAI) SCI & TECH CO LTD
  • DIARRHEA - PIPELINE BY AEGIS THERAPEUTICS LLC

THE COMPANY OFFERS INTRAVAIL, A DRUG DELIVERY TECHNOLOGY THAT ENABLES THE NON-INVASIVE DELIVERY OF A BROAD RANGE OF PROTEIN, PEPTIDE, AND NON-PEPTIDE DRUGS.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • Company
  • Product Initiative

Advanced Drug Delivery Reviews; ##(##): ##-## Renald O, et al. (2009).

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Deals & Alliance
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

DRUG/ MOLECULE REFERS TO PRIMARY INTERVENTION ONLY. ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • CHEMOTHERAPY INDUCED NAUSEA AND VOMITING - PIPELINE BY DAEWOONG PHARMACEUTICAL CO LTD
  • CHEMOTHERAPY INDUCED NAUSEA AND VOMITING - PIPELINE BY HERON THERAPEUTICS INC

The company offers its products through its proprietary FluidCrystal drug delivery technologies such as injection depot, topical bioadhesive delivery, and nanoparticle delivery technologies.

  • Chemotherapy
  • Gastrointestinal Drug
  • Neurological Disorder
  • Pharmaceutical
  • Product Initiative